A novel type of DNA-binding domain, the 'T-box' domain, characterizes an increasingly large family of transcription factors (Trends Genet. 15 (1999) (1999) 133) have virtually identical onset, at around E10.5, and expression domains in the mouse telencephalon. While Tbr1 is expressed in postmitotic neurons, Tbr2 (which is also expressed during gastrulation is also expressed in neural progenitors. We have used in situ hybridization to determine the temporal and spatial distribution of T-bet/Tbx21 expression during mouse development. T-bet/Tbx21 expression is exclusively restricted to the olfactory bulb and the thymus. To assess the distribution of T-BET/ TBX21 expression in the haematopoietic compartment we used reverse transcriptase-polymerase chain reaction and found its expression in several human blood cell lineages, including progenitors/stem cells, immature B cells and peripheral T cells. q
Results and discussion

Sequence comparison of the T-bet/Tbx21 gene
Sequence comparison analysis revealed that the T-bet/ Tbx21 gene (Zhang and Yang, 2000; Szabo et al., 2000; Mullen et al., 2001; Szabo et al., 2002 ) is a new member of the TBR subgroup of T-box genes (Papaioannou et al., 1998; Smith, 1999) , as it shows 85% similarity and 75% identity with the T-box domain of TBR1, eomesodermin/ TBR2 proteins (Bulfone et al., , 1999 . The degree of sequence conservation is much lower in the N-and the Ctermini (around 25% identity) (Fig. 1 ).
Expression of T-bet/Tbx21 during mouse embryonic development
As shown in Figs. 2A and 3A T-bet/Tbx21 expression is first detected at 14.5 days of mouse gestation in the accessory olfactory bulb (AOB). By E16.5, the expression extends to the mitral cell layer (MCL) of the entire main olfactory bulb (OB) (Figs. 2C, E and 3D) where it persists in the adult (Fig. 2F) . The olfactory bulbs are evaginations from the cerebral hemispheres, and are composed of three major cell types: projecting neurons (the mitral and tufted cells), local inhibitory interneurons (periglomerular and granule cells), and glial cells. In the adult olfactory bulb T-bet/Tbx21 maintains wide and high expression in the mitral cell layer as well as in a few scattered cells of the glomerular layer (GL) (Fig. 2I) , while Tbr1 is equally expressed in the periglomerular and mitral cells (Fig. 2G) , and eomesodermin/Tbr-2 is more expressed in the GL (Fig.  2H) . At E16.5, the transcript can also be detected in another structure: the thymus (Fig. 2E) 3C, F, Tbr1 is expressed in the location of postmitotic projection neurons, suggesting that it may function in the control of differentiation of mitral and tufted cells. Further evidence that T-bet/Tbx21 is expressed in mitral cells comes from analysis of its expression in the olfactory bulb in Tbr1 mutant mice. These mutants have a severe reduction in the number of mitral cells (Bulfone et al., 1998) . Consistent with this, T-bet/Tbx21 expression is not detectable at E16.5 in the mutant olfactory bulb (Fig. 3G ).
Expression of T-BET/TBX21 in human haematopoietic compartment
To examine the expression of the T-BET/TBX21 gene in the haematopoietic compartment, reverse transcriptasepolymerase chain reaction (RT-PCR) analysis was performed on RNA samples prepared from a range of distinct human blood cell lineages. CD3
1 T cells, CD19
1 B cells, CD56 1 NK cells, and CD14 1 monocytes, were purified from human peripheral blood by FACS sorting. As shown in Fig. 4A , the T-BET/TBX21 transcript was found only in CD3 1 and CD56 1 cells. To examine whether T-BET/TBX21 is expressed in haematopoietic progenitor/ stem cells, CD34 1 cells were purified by FACS sorting from human bone marrow (bm) and umbilical cord blood (cb). RT-PCR was performed on RNA extracted both from fresh CD34 1 cells and from cells kept in culture for 3 days (bm 3d, cb 3d) in 10% IMDM (Iscove's modified Dulbec- co's medium) in the presence of the cytokines IL-3, IL-6 and SCF, conditions that allow differentiation and commitment of the progenitor cells towards the myeloid lineage (Hao et al., 1998) As shown in Fig. 4B , T-BET/TBX21 transcript could be detected only in the progenitor cells (day 0), but not in the cultured cells, and this result is in agreement with the absence of T-BET/TBX21 expression in CD14 1 cells (Fig.  4A) . To further investigate the expression profile of T-BET/ TBX21 in the differentiating immune system, immature B cells were purified by FACS sorting from the CD34 negative fraction of human bone marrow, and as shown in Fig. 4C , the CD10
1 sIgM 1 cells were positive for T-BET/TBX21.
Materials and methods
Flow cytometry
Surface staining of umbilical cord blood and bone marrow mononuclear cells was performed using the following mAbs: PE-coniugated anti-CD34 (Becton Dickinson, San Jose, CA), PE-conjugated anti-CD3, anti-CD19, FITC-conjugated anti-CD14, anti-CD56 (Becton Dickinson, San Jose, CA), anti-CD10 (Caltag, Burlingame, CA), anti-sIgM (Southern Biotec Associated, AL).
Cell sorting
Cell sorting was performed using FACStar (Becton Dickinson). A lymphocyte-sorting gate was established for both forward and side scattering. Then gates displaying PE fluorescence and FITC fluorescence were generated, and cells were sorted.
RT-PCR amplification
Total RNA was extracted from sorted cells and 2 mg of total RNA was transcribed in 20 ml. Two to 2.5 ml of the resulting cDNA was used in PCR amplifications using pairs of the following primers: 5 0 -AAGTGGGTGCAGTGTG- 
In situ hybridization analysis
Radioactive in situ RNA hybridization was performed as described in Qiu et al. (1995) . Ribobrobes were made from the following cDNA templates: Tbr1 , Tbr2 (Bulfone et al., 1998) and T-bet/Tbx21 (1 kb, PCR-generated). 
